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Abstract Most commercial transgenic crops are
genetically engineered to produce new proteins.
Studies to assess the risks to human and animal health,
and to the environment, from the use of these crops
require grams of the transgenic proteins. It is often
extremely difficult to produce sufficient purified
transgenic protein from the crop. Nevertheless, ample
protein of acceptable purity may be produced by over-
expressing the protein in microbes such as Escherichia
coli. When using microbial proteins in a study for risk
assessment, it is essential that their suitability as
surrogates for the plant-produced transgenic proteins
is established; that is, the proteins are equivalent for
the purposes of the study. Equivalence does not imply
that the plant and microbial proteins are identical, but
that the microbial protein is sufficiently similar
biochemically and functionally to the plant protein
such that studies using the microbial protein provide
reliable information for risk assessment of the trans-
genic crop. Equivalence is a judgement based on a
weight of evidence from comparisons of relevant
properties of the microbial and plant proteins, includ-
ing activity, molecular weight, amino acid sequence,
glycosylation and immuno-reactivity. We describe a
typical set of methods used to compare proteins in
regulatory risk assessments for transgenic crops, and
discuss how risk assessors may use comparisons of
proteins to judge equivalence.
Keywords Risk assessment  Surrogate protein 
Bioactivity  Intactness  Post-translational
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Introduction
Most transgenic crops for commercial use have been
genetically engineered to produce new proteins.
Among other things, the proteins may improve the
crop’s resistance to insect attack, confer tolerance to
various herbicides, make the crop more nutritious,
improve its processing properties, or act as markers to
identify the crop. Risk assessments for the consump-
tion or cultivation of such crops use studies that test
relevant properties of the novel protein to predict the
likelihood that the crops will harm human health or the
environment (He´rouet et al. 2005; Craig et al. 2008;
Romeis et al. 2008; Sanvido et al. 2012).
Many studies for risk assessment require grams of
highly (C90 %) pure protein. Often it is not possible to
prepare the required amount of purified protein from
transgenic plants because the proteins are produced in
low amounts and their purification from the plant
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matrix is technically extremely difficult, if not impos-
sible (He´rouet et al. 2005). It is, however, relatively
easy to produce sufficient protein of acceptable purity
by over-expressing the protein in fermentable
microbes, such as Escherichia coli. Microbial proteins
can be purified from disrupted bacterial cells using
standard methods, including precipitation and chro-
matography. After purification, the protein is concen-
trated, desalted and, in most cases, lyophilised. The
resulting powder is a microbial test substance, which is
used to measure properties of the protein considered
relevant for assessing risks.
For non-pesticidal proteins, the requirement for
large amounts of protein is mainly due to mammalian
toxicity studies. A typical study for evaluation of acute
oral toxicity (e.g., based on the US Environmental
Protection Agency guideline OCSPP (formerly OP-
PTS) 870.1100 requires a minimum of 5 male and 5
female mice each to be given a single dose of at least
2,000 mg protein per kg body weight. Depending on
the weight of the animals, this study alone can use
about 2 g of protein. Sometimes, a repeated-dose oral
toxicity study is used (e.g., based on OECD guideline
407). Such studies require a minimum of 5 male and 5
female mice each to be given a single dose of at least
1,000 mg protein per kg body weight daily for
28 days, which may require over 25 g of active
protein (Delaney et al. 2008).
In addition to mammalian toxicology studies,
regulations require pesticidal proteins to undergo
ecotoxicology testing, and some of the studies may
use large amounts of protein. A typical study of acute
oral toxicity in birds (e.g., based on US EPA guideline
OCSPP 850.2100) requires a minimum of 5 male and 5
female birds (usually bobwhite quails) each to be
given a single dose of at least 2,000 mg protein per kg
body weight, representing over 2 g of protein. Studies
of honey bee brood (Oomen et al. 1992) may expose
each of 3 hives to 1 L of sucrose solution containing
the protein at 10 times the concentration in the pollen
of the transgenic crop. If the pollen contains 50 lg
protein per g fresh weight, and the density of sucrose
solution is 1.2 g/ml, 1.8 g of protein would be needed
for the study.
High purity of the protein test substance aids
interpretation of the results of studies. If adverse
effects are observed in a toxicology or ecotoxicology
study, one needs to be confident that the effects are
caused by the protein and not by an impurity in the test
substance. In some ecotoxicology studies, it is possible
to expose animals to high concentrations of protein via
diets containing tissue from the transgenic crop.
Statistically significant differences between groups
of organisms fed material from a transgenic crop and
groups fed similar non-transgenic crop tissue are
common (e.g., Wandeler et al. 2002; Obrist et al. 2006;
Faria et al. 2007; Rosi-Marshall et al. 2007; Bøhn et al.
2010). Interpretation of such results regarding effects
of the transgenic protein is difficult because the
transgenic and non-transgenic crops differ by more
than just the presence or absence of the transgene, and
therefore the test materials almost certainly differ by
more than just the presence or absence of the protein
coded by that transgene (e.g., Parrott 2008).
While there are clear advantages of microbial test
substances for regulatory studies, it is essential that the
substances are properly characterised. Their purity
must be estimated so that the correct amount of test
substance is used to give the required amount of
protein in a given study. Information about solubility
is crucial as many studies require aqueous solutions of
the test substance. Failure of the test substance to
dissolve or remain in solution could invalidate a study.
It is also crucial to show that the protein in the
microbial test substance is a suitable surrogate for the
protein produced by the transgenic crop, because there
may be intended or unintended differences between
the microbial and plant proteins. Corroboration of the
hypothesis of no significant difference between the
microbial and plant proteins in relevant properties is
taken as evidence that the proteins are functionally and
biochemically equivalent for the purposes of studies
that inform risk assessments for the transgenic crop.
This paper provides an overview characterisation
and equivalence1 studies for microbial test substances
that support their use in risk assessment studies as
surrogates for plant-expressed proteins. Its purpose is
to show the variety of data that is produced in order to
judge the robustness and applicability to transgenic
crop risk assessments of studies that use microbial test
substances. The paper does not provide exhaustive
detail about experimental design, nor does it provide a
1 Studies may be conducted to test whether a protein produced
in one transgenic event is functionally and biochemically
equivalent to the protein produced in a second transgenic event.
These are often termed ‘‘bridging studies’’, but are identical to
the equivalence studies described here.
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complete set of data for a single test substance, such as
provided by Fuchs et al. (1993a, b), Gao et al. (2004,
2006b) and He´rouet et al. (2005). Instead, it concen-
trates on general principles, summaries of current
methods, potential problems and interpretation of
multiple lines of evidence to provide an up-to-date
review of current practice in establishing the suitabil-
ity of microbial proteins to act as surrogates for plant-
produced transgenic proteins.
As discussed below, a microbial test substance need
not be identical to the plant protein for which it is a
surrogate. Equivalence means that the microbial and
plant proteins are deemed sufficiently similar for the
purposes of specific studies that contribute data for
risk assessments. An important corollary of this
definition is that it is not feasible to devise a procedure
that will determine equivalence for all test substances
for all uses. The methods described below should be
regarded as options for a risk assessor to build a weight
of evidence to judge whether or not an individual test
substance is suitable for a particular use. They are not a
series of tests that trigger an objective ‘‘pass’’ or ‘‘fail’’
decision based on universal criteria that distinguish
equivalence from non-equivalence.
Methods for characterising test substances
Solubility
Determination of the solubility of a protein test
substance in aqueous solutions is essential for its
further characterisation because most analytical tech-
niques require the substance in a solubilised form. The
solubility determination of a protein test substance is
therefore commonly the first experiment conducted
during test substance characterisation. Furthermore,
the solubility determination provides important infor-
mation about the possible delivery vehicles in animal
toxicity studies and non-target organism effects
studies.
The solubility of microbial test substances in water
and other aqueous solutions can be determined by a
simple optical test. Defined volumes of the solvent are
added to the lyophilised test substance and its solubil-
ity—the highest concentration at which the test sub-
stance is dissolved completely—is determined by visual
inspection, or confirmed by analytical methods of total
protein determination described below, or both. For
toxicology studies, solubility of the test substance in
water is desirable because it eliminates the possibility of
side effects from other components of the solvent, such
as buffers. Unfortunately, many protein test substances
have limited solubility in water, meaning that buffers
such as tris(hydroxymethyl)methylamine (TRIS), N-
cyclohexyl-3-aminopropanesulfonic acid (CAPS), or
various phosphate buffers are often required to dissolve
test substances. Other additives, such as ethylenediami-
netetraacetic acid (EDTA) dithiothreitol (DDT) or
Tween20 may also be needed to stabilise the protein
in the solution. For some studies, such as acute oral
toxicity in mice, a homogenous suspension of test
substance may be an acceptable alternative to a solution.
In studies that require aqueous solutions of the
protein test substance, the best buffer is the simplest
one that maintains the test substance in solution for the
period of use. Where buffers are used, it may be
necessary to determine whether they significantly
affect the results. In non-target organism effects
studies, for example, preliminary experiments to
determine the effect of the buffer on the test species
are advisable, and inclusion of control groups exposed
to buffers in effects studies should be considered
(Romeis et al. 2011). Sometimes it is possible to
modify study designs to cope with test substances that
are difficult to dissolve. The effect of proteins on the
development of honeybee brood may be determined
by exposing hives to an aqueous solution of sucrose in
which the test substance is dissolved. The sucrose
solution is placed in feeders near the hive, and worker
bees carry solution back to the hive and feed it to the
developing brood (Oomen et al. 1992). For test
substances that are easily maintained in solution, the
required amount of protein could be delivered to a hive
in a single 1L batch of treated sucrose solution placed
near the hive at the beginning of the experiment. For
test substances that are difficult to keep in solution
over a longer period, each hive could be exposed to
200 ml of treated solution on each of the first 5 days of
the study.
Purity
The purity of a microbial test substance is usually
determined in two stages. First, the proportion of the
test substance that is protein is determined using
standard laboratory methods such as BCATM (bi-
cinchoninic acid) (Hill and Straka 1988; Walker
Transgenic Res (2013) 22:445–460 447
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1996), Bradford analyses (Bradford 1976), or, in cases
of highly pure ([90 %) test substance preparations,
spectrophotometrically by measuring absorbance at
280 nm (Gill and von Hippel 1989). Secondly, the
proportion of protein that is the protein of interest
(POI) is determined by sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) of
the protein test substance, followed by staining with
Coomassie Blue and quantitative densitometry (Fish-
bein 1971). The proportion of total protein comprising
the POI is calculated as the area under the peak
representing that protein divided by the total area
under all peaks. The purity of the test substance is
simply calculated as the proportion of the test
substance comprising protein multiplied by the pro-
portion of protein comprising the POI. Figure 1 shows
a typical densitometric analysis of a Coomassie Blue
stained SDS-PAGE gel.
The purity of a protein test substance is reported as
per cent POI weight-by-weight. The purity of the
protein test substance provides information for further
analysis of the protein test substance, and for accurate
dosing of the POI in mammalian toxicity and non-
target organism effects studies.
Highly pure test substances ([90 % POI) are
preferred, because they reduce the probability of
adverse effects arising from impurities such as
proteins from the E. coli expression system (e.g.,
Franken et al. 2000). High purity test substances also
allow the highest possible dosing of the POI at a
minimal volume to animals by gavage where limit
doses are required for acute toxicity exposure studies
in rodents.
Measures of test substance equivalence
Intactness and immuno-reactivity
Analysis of the molecular weight of the microbial and
plant proteins provides information on whether they
have been truncated or degraded in a sample; there-
fore, molecular weight is commonly called a measure
of intactness. Molecular weight determination can also
detect modifications of proteins, such as glycosylation,
and insertions or deletions of amino acids. Immuno-
reactivity refers to the ability of a protein to bind
specific antibodies. Loss of immuno-reactivity may
Fig. 1 Coomassie Blue stained SDS-PAGE gel of a microbial
produced Vip3Aa19 test substance analyzed by densitometry.
a Coomassie stained SDS-PAGE gel. Lanes 1 and 7 Molecular
weight standard SeeBluePlus2 (Invitrogen; bands indicated as
kDa); lanes 2, 3, 4, 5 and 6 0.3, 0.6, 1.2, 2.4, 4.8 lg protein test
substance. The molecular weight of Vip3Aa19 corresponds to
ca. 89 kDa. b Densitometric analysis of the Coomassie stained
SDS-PAGE gel using a laser densitometer. The signals derived
from the individual protein bands are translated into peak areas
(indicated by the numbers on the gel and on the densitometry
graph). The peak areas signal can be used to calculate the
percentage of each protein within the total protein fraction of the
test substance. The analysis showed that the protein comprising
the protein of interest (Vip3Aa19) represented 91.4 % of the
total protein fraction in the test substance. (Color figure online)
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indicate modifications to a protein that change its
biochemical or functional properties.
Western blot analysis, also known as protein
immuno-blotting, is a convenient method for compar-
ing the intactness and immuno-reactivity of protein
samples. In western blotting, proteins are separated by
SDS-PAGE and transferred from the gel to a mem-
brane in a second electrophoresis step called ‘‘blot-
ting’’ (Burnette 1981). The proteins are immobilised on
the membrane, which thereby acquires an exact copy of
the original protein gel image. Once blotted, the POI
can be detected using specific antibodies, allowing the
POI to be identified in complex mixtures such as
protein crude extracts from plants. Western blot
analysis displays the apparent molecular weight of
the POI by comparing its electrophoretic mobility with
that of a molecular weight standard. Kurien and
Scofield (2006) provide a recent review of western
blotting techniques.
Western blotting is a powerful technique for analysis
of the immuno-reactivity and intactness of proteins of
interest from different matrices. Side-by-side compar-
ison of the apparent molecular weight of the proteins
from different sources provides compelling evidence for
equivalence because major differences in modification
of the proteins would result in changes in mobility.
Confirmation of the intactness of a protein within its
matrix also supports the reliability of associated ELISA
analyses, as breakdown of the protein could lead one to
over-estimate its concentration.
An example of western blotting to compare the
intactness and immuno-reactivity of a microbial and
plant POI is shown in Fig. 2. The analysis shows that
mEPSPS derived from recombinant E. coli and from
GA21 maize bind rabbit anti-EPSPS polyclonal anti-
bodies, and have the same apparent molecular weight.
The loss of resolution observed for the mEPSPS
protein bands derived from the maize crude extract is
explained by the interference from large amounts of
protein derived from the plant matrix. The endogenous
maize EPSPS in the negative control (non-transgenic)
maize extract appears as a faint band because the
antibody is not able to discriminate between the native
maize EPSPS and mEPSPS.
Intact mass
The determination of the molecular weight of a protein
by western blots is relatively imprecise (Sadeghi et al.
2003). Exact estimates of intact protein masses can be
obtained by mass spectrometry (MS). Two MS
methods can be used to determine the intact mass of
both microbial and plant proteins: electrospray MS,
often implemented on a quadrupole-time-of-flight (Q-
TOF) type mass spectrometer, and Matrix Assisted
Laser Desorbtion Ionisation (MALDI) MS on a
MALDI-TOF instrument (Sundqvist et al. 2007).
For MS analysis of microbial proteins, Q-TOF
analysis is preferred because it achieves higher mass
accuracy than MALDI-TOF analysis (Sundqvist et al.
2007). Q-TOF machines are able to distinguish
between proteins with single amino acid substitutions,
or other low molecular weight modifications, such as
methionine oxidation. Such differences would not be
detected by MALDI-TOF MS. Plant-produced POIs
can in principle be analysed by either Q-TOF or
MALDI MS. MALDI is currently the method of
choice because its greater sensitivity enables analysis
of small amounts of plant POIs that are difficult to
obtain in large, pure batches (He´rouet et al. 2005).











Fig. 2 Western blot analysis of mEPSPS from recombinant E.
coli and from transgenic maize. Lane 1 Molecular weight
standard SeeBluePlus2 (Invitrogen; bands indicated as kDa);
lanes 2 and 3 7.5 and 15 ng mEPSPS microbial mEPSPS,
respectively; lanes 4 and 5 7.5 and 15 ng mEPSPS from GA21
maize (crude extract), respectively; lanes 6 and 7 7.5 and 15 ng
mEPSPS from GA21 maize (purified using immunoaffinity
chromatography), respectively; lanes 8 and 9 3.5 and 6.9 lg
total protein from non-transgenic maize, respectively. The
molecular weight of mEPSPS corresponds to about 47.4 kDa
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Obtaining the precise mass of the POI provides
direct evidence about the form of the protein present in
the transgenic crop, and can make a strong case for
sequence identity with the microbial protein; for
example, one may be able to demonstrate that the
plant protein is processed in a particular way, whether
or not it has a leader sequence, or that it has not been
unexpectedly glycosylated. No other method can
provide such detail about the chemical form of the
intact protein within the plant.
Analysis of the intact mass of plant-produced POIs
by MS presents significant problems. First, sufficient
POI must be isolated from the plant and concentrated
into a small volume (a few lL). Secondly, the POI must
be of high purity, so that peaks from contaminating
proteins or other compounds do not confound the
analysis. In general, these problems are reduced the
higher the concentration of the POI in the transgenic
plant. Thirdly, the isolation method must not modify the
mass of the POI. Polyphenol oxidation during extraction
is a particular problem (Le Bourvellec and Renard 2012)
and methods to reduce it, such as including in extraction
buffers compounds that adsorb phenols (e.g., Loomis
and Battalie 1966), may be necessary.
Protein sequence
The amino acid sequence of a protein provides useful
information about its likely structure and function
(e.g., Eisenhaber et al. 1995); therefore, amino acid
sequence comparisons are conducted as tests of the
biochemical and functional equivalence of microbial
and plant proteins. Two methods are used routinely:
N-terminal sequencing and peptide mass mapping.
N-terminal sequences of both microbial and plant-
produced POIs can be determined using Edman sequenc-
ing (Edman and Begg 1967). The POI is converted to a
phenylthiocarbamyl protein by reaction of the N-terminal
amino acid with phenylisothiocyanate. The modified
N-terminal amino acid is released by cleavage with
trifluoroacetic acid and converted to a phenylthiohydan-
toin, which can be identified after separation by chroma-
tography or electrophoresis. The amount of sequence
obtainable is limited because the conversion reactions do
not go to completion. However, the sequence of the first
10 amino acid residues can almost always be determined
for a microbial protein, and where sequence can be
obtained for plant protein the comparison is straightfor-
ward. Edman data are semi-quantitative and are able to
detect mixed N-terminal forms should they be present in
plant or microbial protein samples. Many plant POIs are
N-terminally modified into forms that are blocked to
chemical sequencing, most commonly by acetylation
(Martinez et al. 2008). In these circumstances, N-terminal
sequence comparison is not possible and MS provides an
alternative approach to confirm the N-terminal amino
acid sequence for the plant POI; however, technical
hurdles, as indicated below, limit its application in many
cases.
Peptide mass mapping is the application of MS to
the characterisation of plant and microbial protein
sequences. Outside plant biotechnology, the term
normally refers to the application of MALDI-peptide
mass fingerprinting methods for protein identification
(Jensen et al. 1997; Ren et al. 2005; Dauly et al. 2006).
Protein identification is considered reliable if the
coverage is at least 15 % of the sequence and 5 or
more peptides are matched (Jensen et al. 1997).
Peptide mass mapping has been used to sequence
proteins for regulatory submissions for transgenic crops;
for example, Gao et al. (2006a) used MALDI-TOF
peptide mass fingerprinting to characterise Cry1A.105
and Cry2Ab produced in MON 89034 maize. Each
protein was separated on an SDS-PAGE gel and then
digested with trypsin (Williams et al. 1997). The masses
of the tryptic fragment peptides were measured using
MALDI-TOF MS (Billeci and Stults 1993) and were
compared with those of the predicted peptides from the
expected amino acid sequence of the respective pro-
teins. Where a mass matched that of a predicted peptide,
the sequence of the peptide was considered assigned as
the expected sequence. The method matched 52
peptides, confirming 43.8 % (516 of 1,177 amino acids)
for full-length Cry1A.105, and matched 32 peptides,
confirming 44.4 % (283 of 637 amino acids) for full-
length Cry2Ab2.
Gao et al. (2004) took a similar approach to the
characterisation of Cry34Ab1 and Cry35Ab1
expressed in Pseudomonas and transgenic maize,
and to Cry1F produced in Pseudomonas and trans-
genic cotton (Gao et al. 2006b). Scott et al. (2006) used
the same gel tryptic digest method but combined it
with single ion monitoring on an electrospray single
quadrupole instrument to compare 2mEPSPS pro-
duced in E. coli and in GHB614 cotton; peptides from
the microbial 2mEPSPS were identified in the cotton
2mEPSPS with a coverage of over 90 % and the
calculated masses for the peptides were identical.
450 Transgenic Res (2013) 22:445–460
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Another approach to identification of tryptic frag-
ments from SDS-PAGE gels uses nano-liquid chro-
matography-MS/MS (LC–MS/MS) conducted on a
Q-TOF instrument (Marvin et al. 2000). Peptide mass
mapping MS/MS data are interrogated with the
Mascot search tool (Perkins et al. 1999) using a
database containing the predicted amino acid
sequence of the plant or microbial protein. Data from
individual peptides confirm parts of the sequence and
together build up a coverage map for the whole
protein. Analysis of the microbial protein is conducted
in the same way and the two coverage maps used to
confirm the presence of the same protein in both plant
and microbial samples. Figure 3 shows the maps for
microbial and plant-derived Vip3Aa19 with 75 % and
71 % coverage of the proteins respectively.
Obtaining MS/MS spectra of peptides at high mass
accuracy enables confirmation of the identity of
individual peptides from the protein digest. Each
MS/MS spectrum contains information about the
amino acid sequence within the peptide, which is not
provided by the other methods. This provides two
advantages: first, protein identity is verified without
the need to achieve high levels of sequence coverage;
and secondly, peptides from contaminating proteins
can be easily shown to not be associated with the
protein of interest. In some cases, the N-terminal
peptide can also be covered, which provides reliable
data regarding the amino acid sequence and would
make the separate N-terminal sequence analysis
indicated above redundant.
No threshold value for percentage of sequence
coverage of a protein obtained from nano-LC–MS/MS
data has been established; however, in the proteomics
field it is common to accept the identification of
proteins in a sample where high quality spectra from
only two peptides unique to the protein of interest have
been recorded (Bradshaw et al. 2006). Indeed more
recently the need for even the second peptide has been
questioned (Gupta and Pevzner 2009).
It is common in peptide mass mapping that the
coverage for the microbial and plant proteins is not
identical. This does not necessarily imply a difference
in sequence between the two proteins. For example in
the case of the data for Vip3Aa19 shown in Fig. 3
coverage of individual peptides and percentage cov-
erage is similar but not identical. This might have
occurred for a number of reasons. The samples might
not have been the same strength and commonly the
plant protein is the weaker sample showing as in this
case lower percentage coverage. In LC–MS/MS, the
process by which the mass spectrometer selects ions
for fragmentation is to some extent random and the
same peptides are not selected for fragmentation in
each run even in comparable runs of an identical
sample (Liu et al. 2004; Elias et al. 2005).
Glycosylation
Over half of the proteins in plants are estimated to be
glycosylated (Apweiler et al. 1999). Glycosylation
typically consists of the addition of complex structures
derived from carbohydrates. Glycosylation can alter
the physiochemical properties of a protein, such as its
tolerance of heat, functional activity, protein folding,
transport and half-life (Sola´ et al. 2007). N-glycosyl-
ation is a common glycosylation motif in plant
proteins (Strasser et al. 2004; Nagels et al. 2012).
The sequence motif Asn-Xxx-Ser/Thr, or in some rare
cases Asn-Xxx-Cys, where Xxx is any amino acid
except Pro, is required for N-glycosylation. The
absence of these sequences can therefore completely
exclude N-glycosylation of the protein. For other
glycosylation types, programs have been developed
using algorithms to predict glycosylation sides with
over 90 % accuracy (Hamby and Hirst 2008), and
provide useful information regarding the glycosyla-
tion potential of a protein.
Glycosylation has been much studied in connection
with potential increased allergenicity (Wilson et al.
2001). However, increasing knowledge of plant gly-
cosylation has recently led to the conclusion that
carbohydrate moieties are probably insignificant as
clinically important allergen determinants (Altmann
2007). Nevertheless, plant proteins are analysed for
glycosylation status in order to detect possible changes
in function as part of protein equivalence assessments.
Transgenic proteins in plants are not intended to be
glycosylated and recombinant proteins produced in E.
coli are not glycosylated (e.g., Baneyx and Mujacic
2004); therefore, demonstrating the absence of glyco-
sylation adds to the weight of evidence that the POI
and the microbial protein are functionally equivalent.
Differences in glycosylation status might be regarded
seriously owing to potential variation in physico-
chemical properties of the proteins. The analysis of
glycosylation in protein equivalence studies is rou-
tinely accomplished using immuno-blot assays.
Transgenic Res (2013) 22:445–460 451
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Proteins are separated by gel electrophoresis and
electro-transferred to a membrane as in western blot
analysis. Once immobilised on the membrane, glyco-
syl-residues are detected using antibodies or sensitive
chemical methods (Haselbeck and Ho¨sel 1990; Wes-
termeier and Marouga 2005) so that only glycosylated
proteins result in visible bands.
Figure 4 shows an immuno-blot glycosylation
analysis of mEPSPS derived from recombinant E.
coli and from extracts of leaf material from transgenic
GA21 maize. Transferrin, a protein known to be
glycosylated, was used as a positive control, and
creatinase, a protein known to be non-glycosylated,
was used as a negative control. The control proteins
were used to confirm the integrity of the assay and to
establish its sensitivity. In this analysis, visualisation
of glycosylated proteins was achieved by chemical
oxidation of glycan moieties, which were then cova-
lently labelled with digoxigenin (DIG), and detected
with an alkaline phosphatase-linked antibody sensitive
to DIG. Alkaline phosphatase catalyzed a colorimetric
reaction resulting in stained bands representing gly-
cosylated proteins. Loading different amounts of the
positive control allowed the sensitivity of the assay to
be estimated. The results indicate that both mEPSPS
proteins are not glycosylated, or that glycan moieties
occur at a frequency of less than one glucose
equivalent per molecule of mEPSPS.
Further evidence about glycosylation status may
be obtained from the western blot analysis compar-
ing the plant-derived protein with the microbial test
substance. Typical plant N-glycosylation patterns
are rather complex and increase the mass from
between 1 and 2 kDa per glycosylation site (Wilson
et al. 2001). Such increases in the total mass of the
plant protein would be evident from a side-by-side




Fig. 3 Amino acid
sequence coverage map for
a the microbial Vip3Aa19





75.2 % of the sequence was
obtained by combining the
results of analyses using
three separate enzymes
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Activity
Many transgenic proteins are enzymes. For these
proteins, it is important to test the hypothesis that the
activity of the protein in the microbial test substance is
equivalent to that of the protein produced in the
transgenic crop. Similarity in activity is a good
predictor of similar biological interactions, such as
mammalian toxicity and effects on non-target
organisms.
Enzyme activity assays vary depending on the
chemistry of the reaction catalyzed. Specific activity is
reported in units per amount of enzyme. Units are
defined for each enzymatic reaction in terms of the
product produced, or the substrate used, over time
under defined conditions. To calculate specific activ-
ity, the concentration of enzyme within the activity
assay must be estimated. This is done routinely by
enzyme-linked immunosorbent assay (ELISA) (Tijs-
sen 1985), a well-established method to quantify
proteins in different matrices. Often ELISA cannot
distinguish between active and inactive proteins,
which can result in inaccurate estimates of specific
activity. Hence activity studies are often conducted on
crude plant extracts to avoid inactivation during
purification of enzymes produced by the transgenic
plant. Another consideration is that the plant matrix
may reduce the specific activity of enzymes because of
the action of proteases and reactive secondary metab-
olites, such as phenols, and other effects such as rapid
pH changes during extraction. The best comparison of
specific activity of microbial and plant-produced
proteins may therefore be between a crude extract
from a transgenic plant and microbial test substance
spiked into extract from a suitable non-transgenic
control plant.
The reduced activity of enzymes in some plant
matrices is illustrated by an example of transgenic
maize resistant to herbicides containing glyphosate.
Glyphosate inhibits 5-enylpyruvylshikimate-3-phos-
phate synthase (EPSPS), an enzyme in the biochem-
ical pathway that synthesises aromatic amino acids
from shikimic acid (Amrhein et al. 1980). Expression
of a modified EPSPS (mEPSPS), containing two
amino acid substitutions, provides glyphosate resis-
tance in Event GA21 maize owing to reduced binding
of glyphosate to the modified enzyme (Dill 2005). The
activities of mEPSPS derived from recombinant E.
coli and from transgenic maize were determined using
a EPSPS-specific activity assay based on the detection
of orthophosphate released during the transfer of the
enolpyruvate moiety of phosphoenolpyruvate to shi-
kimate 3-phosphate (Stalker et al. 1985). The released
phosphate is detected by its forming a complex with
Malachite Green and molybdate under acid condi-
tions, which is detected by spectrophotometry at
660 nm (Itaya and Ui 1966; Lanzetta et al. 1979).
The microbial mEPSPS had about 9 times the
specific activity of the plant enzyme (Table 1).
However, when the microbial enzyme was added to
an extract from non-transgenic maize, the specific
activity of the microbial enzyme was only about twice
that of the plant enzyme, indicating that the maize
extract inhibits mEPSPS activity. This is important
information when judging whether the microbial
mEPSPS is a suitable surrogate for the plant-produced
EPSPS.
The activity of pesticidal proteins is measured as the
concentration or dose of the toxin that affects a given
proportion of individuals of a test organism in a certain
time. For insecticidal proteins, such ‘‘bioactivity’’ is









Fig. 4 Glycosylation analysis of mEPSPS from recombinant E.
coli and transgenic GA21 maize. Lanes 1, 2 and 3 100, 50,
25 ng, transferrin (positive control, molecular weight of ca.
80,000 and contains ca. 5 % glycan moieties by weight),
respectively; lane 4 2,000 ng creatinase (a nonglycosylated
protein used as negative control); lane 5 molecular weight
standard SeeBluePlus2 (Invitrogen; bands indicated as kDa);
lane 6 732 ng microbial produced mEPSPS protein; lanes 7 and
8 732 and 1,463 ng plant produced mEPSPS protein. The
expected molecular weight of mEPSPS is indicated by the arrow
on the right side of the gel
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usually reported as an LC50, the concentration of the
toxin that kills 50 % of a sensitive test insect a certain
time after exposure to the toxin. While enzyme activity
assays should be reproducible within ranges estab-
lished during the assay validation, insect bioassays are
expected to have greater within- and among-assay
variability than enzyme assays in their absolute
responses owing to biological variation among the
individual insects tested (Robertson et al. 1995). To
minimise extraneous variation, tests of biological
equivalence of insecticidal proteins from plant and
microbial sources, bioactivity should be estimated
concurrently under uniform conditions using individ-
uals from the same cohort of insect larvae randomly
allocated to treatments (Romeis et al. 2011).
Bioactivity is usually assessed using a target pest of
one of the transgenic events that the equivalence study
will support. If the target pest is difficult to rear in the
laboratory, or shows variable responses to a protein, a
non-target pest species may provide a more rigorous
test of the hypothesis of no difference in bioactivity;
for example, the target pest of Cry3Bb1 produced in
MON863 maize is western corn rootworm (Diabrotica
vergifera vergifera), but Colorado potato beetle (CPB;
Leptinotarsa decemlineata) is preferred for bioassays
of Cry3Bb1 because of its greater sensitivity to the
protein (e.g., Duan et al. 2008).
Comparisons of bioactivity may be particularly
useful when the microbial protein is known to differ
from the plant protein in amino acid sequence because
of point mutations in the transgene that occurred
during or after plant transformation. An example is
Vip3A, an insecticidal protein isolated from the
vegetative cells of Bacillus thuringiensis. Vip3Ais
toxic to several lepidopterous pests of maize and
cotton (Lee et al. 2003), and provides control of these
pests when produced in transgenic crops. Vip3A
produced in VipCot cotton (Kurtz et al. 2007) and
Pacha maize (Dively 2005) is a 789 amino acid protein
denoted Vip3Aa19. Vip3A produced in MIR162
maize is also 789 amino acids long, but differs from
Vip3Aa19 by one amino acid: isoleucine instead of
methionine at position 129. The protein in MIR162
maize is denoted Vip3Aa20. The change from methi-
onine to isoleucine at position 129 is a conservative
substitution. Both amino acids are uncharged, nonpo-
lar and have similar molecular weights (149 vs 131);
thus, the difference in amino acids is unlikely to
change the three dimensional structure of the protein.
An additional reason for expecting similar properties
of Vip3Aa19 and Vip3Aa20 is that the amino acid
difference occurs outside the protein tryptic core (Lee
et al. 2003).
Studies using microbial test substances containing
Vip3Aa19 have been used to support risk assessments
for MIR162 maize (Raybould and Vlachos 2011). In
surface incorporation bioassays using first-instar Spo-
doptera frugiperda (Fall armyworm), the 120-hour
LC50 estimated from 3 independent bioassays was
137 ng Vip3A/cm2 (95 % CI = 82–199) for micro-
bial Vip3Aa19, and 154 ng Vip3A/cm2 (95 %
CI = 94–222) for Vip3Aa20 from MIR162 maize.
The similar bioactivity was part of the justification for
using Vip3Aa19 studies to support risk assessments
for MIR162 maize (US EPA 2009).
Corroboration of the hypothesis that the microbial
and plant test substances do not have different
activities is important for interpreting the results of
toxicity and ecotoxicology studies. If the activity of
the microbial protein is no different from that of the
plant protein, then the dose or concentration of
microbial protein used in a study can be compared
directly with predicted environmental concentrations
of proteins that may result from cultivation of the
transgenic crop. Suppose that several representative
surrogate non-target organisms are exposed to diets
containing a microbial protein at 500 lg/g diet with no
observable adverse effects, and that predicted highest
exposures of non-target organisms to the protein via
cultivation of the transgenic crop are no greater than
50 lg/g diet. Provided that dietary exposure in the test
diet is confirmed, it follows that one can infer with
high confidence that the no observable adverse effect
concentration (NOAEC) of the protein to all species
represented by the tested surrogates is greater than or
equal to their highest exposure in the field (the worst-
Table 1 Comparison of the specific activity of mEPSPS from
various sources
Sample Mean specific activity (Units/
mg mEPSPS) ± SD
Microbial mEPSPS 6,700 ± 32
GA21 maize mEPSPS 734 ± 16
Microbial mEPSPS ? non-
transgenic maize extract
1,560 ± 21
One unit of mEPSPS activity is defined as the release of
1 nmol of phosphate per minute under standard assay
conditions (Padgette et al. 1987)
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case expected environmental concentration or EEC).
In risk assessments this may be presented as a hazard
quotient (HQ): EEC/NOAEC B0.1 (Raybould et al.
2011). This would be strong corroboration of the
hypothesis that non-target organisms will not be
exposed to harmful concentrations of the protein via
cultivation of the transgenic crop (e.g., Raybould et al.
2007).
If the hypothesis that the microbial and plant
proteins do not have different activity were rejected, it
would not necessarily mean that the microbial test
substance is unsuitable for risk assessment studies. If
other studies show that the proteins are equivalent
apart from activity, the difference in activity could be
allowed for in risk assessments. In the example above,
if the microbial protein were found to have half the
activity of the plant protein, that is the LC50 of the
microbial protein is twice that of the plant protein, then
one could correct the estimate of the NOAEC to half
the value based on the concentration of the protein the
microbial test substance. After correction for bioac-
tivity, the HQs would be B0.2—still strong corrobo-
ration of the hypothesis of no harm to non-target
organisms, but giving a little less confidence in a
conclusion of negligible risk compared with studies
done with a test substance of equivalent activity to the
plant protein. Finally, one could argue that greater
potency of the protein in the microbial test substance
may allow a higher NOAEC to be set for risk
assessments of the transgenic crop containing the less
potent protein; however, in practice this is unlikely to
be convincing as lower activity of the plant protein
may be due to effects of the plant matrix or to
inactivation during purification, not to intrinsically
higher activity of the microbial protein.
To date, the desired traits of most commercial
transgenic crops are based on the production of
proteins that are enzymes or toxins. Methods to
measure the activity of these proteins are conceptually
straightforward. New traits may be based on proteins
that are not so simple to assay for activity. One method
of increasing water-use efficiency of maize is the
production of a cold-shock protein derived from
Bacillus subtilis (CSPB). CSPB binds to single-
stranded DNA or RNA. Its binding activity may be
revealed in vitro by fluorescence from a labelled
double-stranded probe as it becomes opened by the
protein (Castiglioni et al. 2008). This assay has been
used to determine the equivalence of a microbial and
plant-produced CSPB (Pester et al. 2009). Water-use
efficiency may also be improved by the production of
new transcription factors (e.g., Kasuga et al. 1999).
There are in vitro methods for determining the
specificity and affinity of transcription factors (Jolma
and Taipale 2011). These methods could fulfil the role
of functional assays when assessing test substance
equivalence in cases where activity assays as
described above are not applicable.
Judging the equivalence of proteins
Microbial and plant proteins may differ in several
ways: the differences may be unintended results of
changes during transformation or test substance pro-
duction, or may be intended to assist production of the
test substance; and the differences may be single
amino acid substitutions, additions of short amino acid
tags, or large deletions of parts of the microbial or
plant proteins.
Unintended differences from the plant protein may
arise during production of microbial protein and these
differences tend to be minor. One common source of
variation is cleavage of the N-terminal methionine
when proteins are produced in microbes and its
retention in plant-produced proteins. Another source
of variation is mutations in the gene for the POI during
transformation of the plant or the microbial expression
vector; mutations tend to result in differences of one or
two amino acid residues between the plant and
microbial proteins (e.g., Raybould and Vlachos 2011).
Occasionally, the microbial protein is designed to
be different from the plant protein. Short tags of 6-10
amino acids such as histidine may be added to the N-
or C-terminus of the microbial protein to aid purifi-
cation (Schmitt et al. 1993). Sometimes, the protein
produced in the plant may be hard to produce in
microbes. For example, many insect-resistant trans-
genic crops produce truncated (or ‘‘activated’’) forms
of Cry proteins. Producing similarly truncated Cry
proteins as microbial test substances is often difficult.
The solubility of Cry proteins varies depending on the
organism in which they are produced (Khasdan et al.
2003), and although truncated Cry proteins are soluble
in plants, they are often insoluble in microbes. In such
cases, one option is to produce a full-length microbial
protein and truncate it by treatment with a protease
such as trypsin (e.g., Porcar et al. 2010). Alternatively,
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it may be possible to use the full-length protein in, for
example, non-target organism effects studies if the
proteins are equivalent in attributes other than length.
The suitability of a microbial protein for a risk
assessment study depends on whether it is determined
to be equivalent to the plant protein in properties
relevant to the purpose of the study. Usually, a weight-
of-evidence approach is taken; that is, no single study
determines whether or not the proteins are equivalent,
and equivalence is determined by evaluation of the
results of several studies such as those described above
and outlined in Table 2. Other lines of evidence, such
as whether for single amino acid differences both
amino acids are neutral or acid, or both are hydrophilic
or hydrophobic, and whether the substitution has
occurred in part of the protein known to determine
important properties such as bioactivity, may also be
considered.
It is important to realise that equivalence does not
imply that the plant and microbial proteins are
identical. Equivalence it is intended to mean that the
microbial protein is sufficiently similar biochemically
and functionally to the plant protein such that studies
using the microbial protein provide reliable
Table 2 Examples of tests to establish equivalence between plant proteins and microbially produced protein surrogates





Detection of potential amino acid





Insertions, truncations or modifications indicate
potential differences in physicochemical
properties including functional activity.
Differences may be acceptable depending on
results of other parameters identified and the
purpose of the safety study
Immuno-reactivity Western blot
analysis
Detection of potential differences
in immuno-reactivity
Differences in binding to specific antibodies
indicate differences in protein structure;
further tests should be conducted to judge
impact on equivalence
Intact mass Mass spectrometry Detection of insertions,
truncations, substitutions and
other modifications with higher






Detection of potential differences
in amino acid sequence
Amino acid sequence contributes to the
structure and function of a protein. Differences
in sequence may be acceptable depending on




Detection of potential differences
in glycosylation status
Glycosylation affects many properties of
proteins including stability and function. It has
been claimed that glycosylation affects the
allergenicity of proteins, although recent work
casts doubt on this suggestion. Nevertheless,
differences in glycosylation status might be
regarded seriously owing to potential variation
in physicochemical properties of the proteins
Functional activity Enzymatic activity
assay, insecticidal
bioassay
Detection of potential differences
in specific catalytic activity
(enzymes) or insecticidal
bioactivity (toxins)
Confirmation of equivalent activities confirms
equivalent protein folding (tertiary and
quaternary structure). Depending on the
results of other equivalence tests, differences
in activity may be acceptable. Differences in
activity may be allowed for in safety studies.
For example, margins of exposure could be
based on comparisons of activity, not
concentration
Equivalence is judged separately for each test substance based on a weight of evidence
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information for risk assessment of the transgenic plant.
‘‘Sufficiently similar’’ cannot be defined completely
objectively, but is a judgement by risk assessors about
whether studies using microbial protein provide
reliable and robust tests of risk hypotheses that the
cultivation of the transgenic plant will not cause harm.
Decisions about the suitability of a particular micro-
bial protein should therefore concentrate on properties
that predict harm, and it follows that the microbial
protein could be deemed sufficiently similar to the
plant protein for some studies but not for others. Those
features that are most important should receive the
most attention, depending on the intended use of the
test substance. For example, equivalent bioactivity
may be most important for non-target organism
studies, similar glycosylation and immuno-reactivity
may be the main requirements for allergenicity
studies, while analysis of amino acid sequence may
be best for determining suitability for studies that
compare enzymatic degradation of proteins.
Conclusions
Safety studies using purified microbial proteins may
provide important data to assess the risks to human and
animal health and to the environment from the use of
transgenic crops (Garcia-Alonso et al. 2006; Delaney
et al. 2008; Romeis et al. 2008). The studies are carried
out to internationally accepted guidelines that specify
factors such as replication, test duration, measurement
endpoints and validity criteria, to maintain the
repeatability and reliability of the studies (Delaney
et al. 2008; Romeis et al. 2011).
The usefulness of a study with microbial protein
does not depend solely on the experimental design
elements noted above. It is also essential that the
microbial test substance is a suitable surrogate for the
plant-produced transgenic protein for the purposes of
the study. Suitability as a surrogate does not imply that
the microbial and plant proteins must be identical,
only that relevant properties of the microbial test
substance and the plant protein are sufficiently similar,
such that studies with the microbial protein reliably
predict the probability of harmful effects that may
result from human, animal or environmental expo-
sures to the protein via the transgenic crop. Variation
in the functions of proteins, the purposes of studies,
and opinions of decision-makers about the relevance
of particular differences between proteins, means that
it is not feasible to define one set of equivalence
criteria that applies to all test substances for all uses.
The suitability of test substances as surrogates must be
judged individually based on a weight of evidence
from studies comparing the microbial and plant
proteins for properties including activity, molecular
weight, amino acid sequence, glycosylation and
immuno-reactivity. Establishment of the suitability
of the test substance, along with experimental designs
that follow international guidelines, will ensure that
studies with microbial protein provide reliable infor-
mation about the risks posed by the use of transgenic
crops.
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